The Company of Biologists renews Read & Publish Open Access agreement with the Max Planck Digital Library (MPDL)

The agreement will run from 1 January 2024 until 31 December 2026, and corresponding authors at Max Planck Society’s 86 institutes can continue to publish research articles immediately Open Access (OA) in our hybrid journals (Development, Journal of Cell Science and Journal of Experimental Biology) and our fully Open Access journals (Disease Models & Mechanisms and Biology Open) without paying an article processing charge (APC).

Researchers at participating institutions also benefit from unlimited access to our hybrid journals, including their full archives dating back to 1853.

For me more information click here.